title: Safe use of efalizumab in a psoriasis patient with chronic heart failure due to hypertrophic cardiomyopathy.
authors.forename: N
authors.initials: N
authors.lastname: Cassano
authors.forename: A
authors.initials: A
authors.lastname: Miracapillo
authors.forename: R
authors.initials: R
authors.lastname: Buquicchio
authors.forename: V
authors.initials: V
authors.lastname: Mastrandrea
authors.forename: G A
authors.initials: GA
authors.lastname: Vena
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications*; D002908:Chronic Disease; D005260:Female; D006333:Heart Failure / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab